Chinese Herbal Therapy Combined With Acupuncture for Female Mixed Urinary Incontinence
Primary Purpose
Urinary Incontinence
Status
Completed
Phase
Phase 2
Locations
China
Study Type
Interventional
Intervention
Chinese herb & acupuncture
Chinese herb & sham acupuncture
Placebo & acupuncture
Placebo & sham acupuncture
Sponsored by
About this trial
This is an interventional treatment trial for Urinary Incontinence focused on measuring Urinary incontinence, Chinese herb, Acupuncture
Eligibility Criteria
Inclusion Criteria:
- (1) female, leaking with urgency and with physical activity, coughing or sneezing (MUI) for more than 1 year; (2) recorded more than 1 incontinent episode per 24 hours in their bladder diary
Exclusion Criteria:
- (1) with acute urinary tract infection; (2) with bladder outlet obstruction, (3) with neurogenic bladder (4) with interstitial cystitis, (5) with pelvic organ prolapse more than stage 2 (6) previous anti-incontinence surgery or a post-void residual urine volume more than 100 mL.
Sites / Locations
- Guang'anmen Hospital, China Academy of Chinese Medical Sciences
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Arm Type
Experimental
Active Comparator
Active Comparator
Placebo Comparator
Arm Label
Chinese herb & acupuncture
Chinese herb & sham acupuncture
Placebo & acupuncture
Placebo & sham acupuncture
Arm Description
Participants will take Yiqi Suoquan granule and receive acupuncture.
Participants will take Yiqi Suoquan granule and receive sham acupuncture.
Participants will take placebo granule and receive acupuncture.
Participants will take placebo granule and receive sham acupuncture.
Outcomes
Primary Outcome Measures
Change in incontinence episode per 24 h
assessed by 72 h bladder diary
Secondary Outcome Measures
Change in ICIQ-SF questionnaire
assessed by ICIQ-SF questionnaire
Change in I-QOL questionnaire
assessed by I-QOL questionnaire
proportion of participants with more than 50% improvement in incontinence episodes per 24h
assessed by 72 h bladder diary
Full Information
NCT ID
NCT03450902
First Posted
February 23, 2018
Last Updated
May 28, 2021
Sponsor
Guang'anmen Hospital of China Academy of Chinese Medical Sciences
1. Study Identification
Unique Protocol Identification Number
NCT03450902
Brief Title
Chinese Herbal Therapy Combined With Acupuncture for Female Mixed Urinary Incontinence
Official Title
Combination Therapy With Chinese Herbal Formula, Yiqi Suoquan Granule, and Acupuncture for Female Mixed Urinary Incontinence
Study Type
Interventional
2. Study Status
Record Verification Date
May 2021
Overall Recruitment Status
Completed
Study Start Date
March 14, 2018 (Actual)
Primary Completion Date
April 18, 2021 (Actual)
Study Completion Date
April 18, 2021 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Guang'anmen Hospital of China Academy of Chinese Medical Sciences
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
The purpose of this study is to determine whether combination therapy with Chinese herbal formula, Yiqi Suoquan granule, and acupuncture is effective in the treatment of female mixed urinary incontinence.
Detailed Description
This factorial, randomized, controlled trial is aimed to assess the effectiveness of combination therapy with Chinese herbal formula, Yiqi Suoquan granule, and acupuncture in the treatment of female mixed urinary incontinence (MUI). Eligible participants will be randomly allocated to receiving combination therapy with Yiqi Suoquan granule and acupuncture, Yiqi Suoquan ganule plus sham acupuncture, placebo plus acupuncture, or placebo plus sham acupuncture.
To minimize the evaluation bias, the outcome assessors and statisticians will be masked to treatment allocation besides participants.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Urinary Incontinence
Keywords
Urinary incontinence, Chinese herb, Acupuncture
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 2
Interventional Study Model
Factorial Assignment
Masking
ParticipantInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
136 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Chinese herb & acupuncture
Arm Type
Experimental
Arm Description
Participants will take Yiqi Suoquan granule and receive acupuncture.
Arm Title
Chinese herb & sham acupuncture
Arm Type
Active Comparator
Arm Description
Participants will take Yiqi Suoquan granule and receive sham acupuncture.
Arm Title
Placebo & acupuncture
Arm Type
Active Comparator
Arm Description
Participants will take placebo granule and receive acupuncture.
Arm Title
Placebo & sham acupuncture
Arm Type
Placebo Comparator
Arm Description
Participants will take placebo granule and receive sham acupuncture.
Intervention Type
Combination Product
Intervention Name(s)
Chinese herb & acupuncture
Other Intervention Name(s)
Yiqi Suoquan granule & acupuncture
Intervention Description
Participants will take Chinese herbal formula, Yiqi Suoquan granule, which is composed of Radix Astragali 30 g, Radix Codonopsis pilosula 10g, Radix Angelica sinensis 10g, Radix Atractylodis Macrocephalae 10g, Fructus Alpiniae Oxyphyllae 10g, Radix Lindera aggregata 6g, Rhizoma Dioscoreae 10g, pericarpium citri reticulatae 10g, Rhizoma Cimicifuga 10g, Radix Bupleuri 10g, Fructus Rubi 15g, and Semen raphani 10g and prepared by the Department of Pharmacy, Guang'anmen Hospital, China Academy of Chinese Medical Sciences. Besides, Participants will receive acupuncture, three times a week. The selected acupoints include bilateral BL33, BL35, SP6, and ST36.
Intervention Type
Combination Product
Intervention Name(s)
Chinese herb & sham acupuncture
Other Intervention Name(s)
Yiqi Suoquan granule & sham acupuncture
Intervention Description
Participants will take Chinese herbal formula, Yiqi Suoquan granule, which is composed of Radix Astragali 30 g, Radix Codonopsis pilosula 10g, Radix Angelica sinensis 10g, Radix Atractylodis Macrocephalae 10g, Fructus Alpiniae Oxyphyllae 10g, Radix Lindera aggregata 6g, Rhizoma Dioscoreae 10g, pericarpium citri reticulatae 10g, Rhizoma Cimicifuga 10g, Radix Bupleuri 10g, Fructus Rubi 15g, and Semen raphani 10g and prepared by the Department of Pharmacy, Guang'anmen Hospital, China Academy of Chinese Medical Sciences. Besides, Participants will receive sham acupuncture, three times a week. The sham BL33, BL35, SP6, and ST36, which are 25 mm outward to BL33, BL35, SP6, and ST36, will be inserted with a depth of 2 to 3 mm.
Intervention Type
Combination Product
Intervention Name(s)
Placebo & acupuncture
Other Intervention Name(s)
placebo granule & acupuncture
Intervention Description
Participants will take Chinese herbal placebo which is prepared by the Department of Pharmacy, Guang'anmen Hospital, China Academy of Chinese Medical Sciences. Besides, Participants will receive acupuncture, three times a week. The selected acupoints include bilateral BL33, BL35, SP6, and ST36.
Intervention Type
Other
Intervention Name(s)
Placebo & sham acupuncture
Other Intervention Name(s)
placebo granule & sham acupuncture
Intervention Description
Participants will take Chinese herbal placebo which is prepared by the Department of Pharmacy, Guang'anmen Hospital, China Academy of Chinese Medical Sciences. Besides, Participants will receive sham acupuncture, three times a week. The sham BL33, BL35, SP6, and ST36, which are 25 mm outward to BL33, BL35, SP6, and ST36, will be inserted with a depth of 2 to 3 mm.
Primary Outcome Measure Information:
Title
Change in incontinence episode per 24 h
Description
assessed by 72 h bladder diary
Time Frame
8 week (post-treatment) and 12 week (follow-up)
Secondary Outcome Measure Information:
Title
Change in ICIQ-SF questionnaire
Description
assessed by ICIQ-SF questionnaire
Time Frame
8 week (post-treatment) and 12 week (follow-up)
Title
Change in I-QOL questionnaire
Description
assessed by I-QOL questionnaire
Time Frame
8 week (post-treatment) and 12 week (follow-up)
Title
proportion of participants with more than 50% improvement in incontinence episodes per 24h
Description
assessed by 72 h bladder diary
Time Frame
8 week (post-treatment)
10. Eligibility
Sex
Female
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
(1) female, leaking with urgency and with physical activity, coughing or sneezing (MUI) for more than 1 year; (2) recorded more than 1 incontinent episode per 24 hours in their bladder diary
Exclusion Criteria:
(1) with acute urinary tract infection; (2) with bladder outlet obstruction, (3) with neurogenic bladder (4) with interstitial cystitis, (5) with pelvic organ prolapse more than stage 2 (6) previous anti-incontinence surgery or a post-void residual urine volume more than 100 mL.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Ran Pang, MD
Organizational Affiliation
Guang'anmen hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
Guang'anmen Hospital, China Academy of Chinese Medical Sciences
City
Beijing
State/Province
Beijing
ZIP/Postal Code
100053
Country
China
12. IPD Sharing Statement
Plan to Share IPD
No
IPD Sharing Plan Description
The agreement for sharing IPD is not designed to be signed in informed consent form.
Learn more about this trial
Chinese Herbal Therapy Combined With Acupuncture for Female Mixed Urinary Incontinence
We'll reach out to this number within 24 hrs